HEPATITIS A VIRUS STRAIN HM175 ANTIGEN: 45 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Drug Class: Actively Acquired Immunity [PE] · Route: ORAL · Manufacturer: Professional Complementary Health Formulas · HUMAN OTC DRUG · FDA Label: Available
First Report: 200010 · Latest Report: 20240301
What Are the Most Common HEPATITIS A VIRUS STRAIN HM175 ANTIGEN Side Effects?
All HEPATITIS A VIRUS STRAIN HM175 ANTIGEN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 16 | 35.6% | 0 | 6 |
| Dizziness | 15 | 33.3% | 0 | 6 |
| Malaise | 15 | 33.3% | 0 | 7 |
| Vomiting | 14 | 31.1% | 0 | 6 |
| Cough | 11 | 24.4% | 0 | 8 |
| Headache | 10 | 22.2% | 0 | 2 |
| Asthenia | 9 | 20.0% | 0 | 8 |
| Nausea | 9 | 20.0% | 0 | 1 |
| Abdominal pain upper | 8 | 17.8% | 0 | 1 |
| Diarrhoea | 8 | 17.8% | 0 | 6 |
| Hyperhidrosis | 8 | 17.8% | 0 | 1 |
| Rash | 8 | 17.8% | 0 | 2 |
| Urticaria | 8 | 17.8% | 0 | 1 |
| Gait disturbance | 7 | 15.6% | 0 | 7 |
| Influenza like illness | 7 | 15.6% | 0 | 0 |
| Memory impairment | 7 | 15.6% | 0 | 1 |
| Multiple sclerosis | 7 | 15.6% | 0 | 6 |
| Abdominal discomfort | 6 | 13.3% | 0 | 6 |
| Acute sinusitis | 6 | 13.3% | 0 | 6 |
| Back pain | 6 | 13.3% | 0 | 0 |
Who Reports HEPATITIS A VIRUS STRAIN HM175 ANTIGEN Side Effects? Age & Gender Data
Gender: 47.5% female, 52.5% male. Average age: 32.1 years. Most reports from: US. View detailed demographics →
Is HEPATITIS A VIRUS STRAIN HM175 ANTIGEN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 2 | 0 | 2 |
| 2001 | 4 | 0 | 4 |
| 2010 | 5 | 0 | 0 |
| 2013 | 2 | 0 | 1 |
| 2014 | 2 | 0 | 0 |
| 2015 | 2 | 1 | 0 |
| 2016 | 1 | 0 | 1 |
| 2018 | 2 | 0 | 0 |
| 2019 | 4 | 0 | 0 |
| 2021 | 2 | 0 | 1 |
| 2022 | 2 | 0 | 0 |
| 2023 | 1 | 0 | 0 |
| 2024 | 1 | 0 | 0 |
What Is HEPATITIS A VIRUS STRAIN HM175 ANTIGEN Used For?
| Indication | Reports |
|---|---|
| Immunisation | 14 |
| Prophylaxis | 12 |
| Product used for unknown indication | 8 |
Other Drugs in Same Class: Actively Acquired Immunity [PE]
Official FDA Label for HEPATITIS A VIRUS STRAIN HM175 ANTIGEN
Official prescribing information from the FDA-approved drug label.
FDA Approved Uses (Indications)
INDICATIONS For the temporary relief of fatigue, nausea, mild abdominal pain, low-grade fever, or feelings of discomfort or uneasiness.*
Dosage & Administration
DIRECTIONS Place drops under tongue 30 minutes before/after meals. Adults and children 12 years and over: Take 10 to 15 drops once weekly or monthly. If mild symptoms are present, take 10 drops up to 3 times per day. Consult a physician for use in children under 12 years of age.
Warnings
WARNINGS Severe or persistent symptoms may be a sign of a serious condition. Consult a doctor promptly if symptoms persist or are accompanied by a fever or yellowing of the skin or eyes. Keep out of the reach of children. In case of overdose, get medical help or contact a poison control center right away. If pregnant or breastfeeding, ask a healthcare professional before use. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use.
Active Ingredient
ACTIVE INGREDIENTS Hepatitis A 16X, 30X, 60X, 100X, 200X Hepatitis B 16X, 30X, 60X, 100X, 200X Hepatitis C 16X, 30X, 60X, 100X, 200X
Inactive Ingredients
INACTIVE INGREDIENTS 20% ethanol, purified water.